Chylomicron Disorders

Chylomicron Disorders is a lipid metabolism disorder characterized by the abnormal production, processing, or clearance of chylomicrons, leading to pathological accumulations of these lipoprotein particles in the bloodstream.

117

Publications

6K

Citations

630

Authors

210

Institutions

Publications per year

2017–2026

30

Authors

630

  1. DG
    Daniel Gaudet

    Université de Montréal, Canada

    12 publications · 1.2K citations

    12

    h-index

  2. JL
    Joseph L. Witztum

    University of California San Diego, United States

    8 publications · 1.1K citations

    8

    h-index

  3. RA
    Robert A. Hegele

    Western University, Canada

    7 publications · 426 citations

    7

    h-index

  4. ÉB
    Éric Bruckert

    Sorbonne Université, France

    6 publications · 972 citations

    6

    h-index

  5. AD
    Andrés Digenio

    Ionis Pharmaceuticals (United States), United States

    5 publications · 975 citations

    5

    h-index

1–5 of 630

Venues

  1. Journal of clinical lipidology

    14 publications · 780 citations

    14

    h-index

  2. Atherosclerosis

    10 publications · 499 citations

    10

    h-index

  3. PubMed

    Repository · 8 publications · 159 citations

    8

    h-index

  4. Metabolism

    7 publications · 339 citations

    7

    h-index

  5. Clinica Chimica Acta

    CCA · 5 publications · 129 citations

    5

    h-index

1–5